Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a northern han chinese population

NeuroMolecular Medicine

Volumn 15, Issue 2, 2013, Pages 279-287

  Ma, Xiao Ying ^a   Yu, Jin Tai ^a,b   Wang, Wei ^a   Wang, Hui Fu ^a   Liu, Qiu Yan ^a   Zhang, Wei ^a   Tan, Lan ^a,b  

^a QINGDAO UNIVERSITY   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Alzheimer's disease; Association study; Polymorphism; TOMM40

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40 HOMOLOG GENE;

AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE TRANSPORT PROTEINS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84877788508     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-012-8217-7     Document Type: Article

References (35)

1. Abramsson, A.; Landgren, S.; Zetterberg, M.; Seibt Palmer, M.; Minthon, L.; Gustafson, D. R.; et al. (2011). No association of LOXL1 gene polymorphisms with Alzheimer's disease. NeuroMolecular Medicine, 13, 160-166.
2. Babakchanian, S.; Hwang, K. S.; Coppola, G.; Klein, E.; Lane, J.; Johnson, S.; et al. (2011). TOMM40 rs2075650, TOMM40 rs157580 and TOMM40 PolyT Polymorphism Effects on Ventricular Enlargement in Individuals with and without Mild Cognitive Impairment. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 7, S47.
3. Barrett, J. C.; Fry, B.; Maller, J.; & Daly, M. J. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
4. Bekris, L. M.; Galloway, N. M.; Montine, T. J.; Schellenberg, G. D.; & Yu, C. E. (2010a). APOE mRNA and protein expression in postmortem brain are modulated byan extended haplotype structure. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B, 409-417.
5. Bekris, L. M.; Lutz, F.; & Yu, C. E. (2012). Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE. Journal of Human Genetics, 57, 18-25.
6. Bekris, L. M.; Millard, S. P.; Galloway, N. M.; Vuletic, S.; Albers, J. J.; Li, G.; et al. (2008). Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. Journal of Alzheimer's Disease, 13, 255-266.
7. Bekris, L. M.; Yu, C. E.; Bird, T. D.; & Tsuang, D. W. (2010b). Genetics of Alzheimer disease. Journal of Geriatric Psychiatry and Neurology, 23, 213-227.
8. Bruno, D.; Pomara, N.; Nierenberg, J.; Ritchie, J. C.; Lutz, M. W.; Zetterberg, H.; et al. (2012). Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants. Experimental Gerontology, 47, 347-352.
9. Campion, D.; Dumanchin, C.; Hannequin, D.; Dubois, B.; Belliard, S.; Puel, M.; et al. (1999). Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. American Journal of Human Genetics, 65, 664-670.
10. Carrasquillo, M. M.; Zou, F.; Pankratz, V. S.; Wilcox, S. L.; Ma, L.; Walker, L. P.; et al. (2009). Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nature Genetics, 41, 192-198.
11. Corder, E. H.; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P. C.; Small, G. W.; et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
12. Cruchaga, C.; Nowotny, P.; Kauwe, J. S.; Ridge, P. G.; Mayo, K.; Bertelsen, S.; et al. (2011). Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Archives of Neurology, 68, 1013-1019.
13. Devi, L.; Prabhu, B. M.; Galati, D. F.; Avadhani, N. G.; & Anandatheerthavarada, H. K. (2006). Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. The Journal of Neuroscience, 26, 9057-9068.
14. Favis, R.; Day, J. P.; Gerry, N. P.; Phelan, C.; Narod, S.; & Barany, F. (2000). Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nature Biotechnology, 18, 561-564.
15. Gabriel, S. B.; Schaffner, S. F.; Nguyen, H.; Moore, J. M.; Roy, J.; Blumenstiel, B.; et al. (2002). The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
16. Gatz, M.; Reynolds, C. A.; Fratiglioni, L.; Johansson, B.; Mortimer, J. A.; Berg, S.; et al. (2006). Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry, 63, 168-174.
17. Grossman, I.; Lutz, M. W.; Crenshaw, D. G.; Saunders, A. M.; Burns, D. K.; Roses, A. D.; et al. (2010). Alzheimer's disease: diagnostics, prognostics and the road to prevention. EPMA Journal, 1, 293-303.
18. Hansson Petersen, C. A.; Alikhani, N.; Behbahani, H.; Wiehager, B.; Pavlov, P. F.; Alafuzoff, I.; et al. (2008). The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proceedings of the National Academy of Sciences of the United States of America, 105, 13145-13150.
19. Harold, D.; Abraham, R.; Hollingworth, P.; Sims, R.; Gerrish, A.; Hamshere, M. L.; et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics, 41, 1088-1093.
20. Humphries, A. D.; Streimann, I. C.; Stojanovski, D.; Johnston, A. J.; Yano, M.; Hoogenraad, N. J.; et al. (2005). Dissection of the mitochondrial import and assembly pathway for human Tom40. Journal of Biological Chemistry, 280, 11535-11543.
21. Hwang, K.S.; Coppola, G.; Johnson, S.; Thompson, P.M.; Lee, J.J.; Ringman, J.M.; et al. (2011). Mapping the effects of TOMM40 and APOE4 on hippocampal atrophy in cognitively normal elderly and MCI. Oral presentation - Alzheimer's Disease Imaging Platform Session at the 2011 AAN meeting.
22. Johnson, S. C.; La Rue, A.; Hermann, B. P.; Xu, G.; Koscik, R. L.; Jonaitis, E. M.; et al. (2011). The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 7, 456-465.
23. Kim, S.; Swaminathan, S.; Shen, L.; Risacher, S. L.; Nho, K.; Foroud, T.; et al. (2011). Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology, 76, 69-79.
24. Lambert, J. C.; Heath, S.; Even, G.; Campion, D.; Sleegers, K.; & Hiltunen, M. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics, 41, 1094-1099.
25. Ma, X. Y.; Yu, J. T.; Wu, Z. C.; Zhang, Q.; Liu, Q. Y.; Wang, H. F.; et al. (2012). Replication of the MTHFD1L gene association with late-onset Alzheimer's disease in a Northern Han Chinese population. Journal of Alzheimer's Disease, 29, 521-525.
26. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
27. Naj, A. C.; Jun, G.; Beecham, G. W.; Wang, L. S.; Vardarajan, B. N.; & Buros, J. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics, 43, 436-441.
28. Potkin, S. G.; Guffanti, G.; Lakatos, A.; Turner, J. A.; Kruggel, F.; Fallon, J. H.; et al. (2009). Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS ONE, 4, e6501.
29. Roses, A. D.; Lutz, M. W.; Amrine-Madsen, H.; Saunders, A. M.; Crenshaw, D. G.; Sundseth, S. S.; et al. (2010). A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics Journal, 10, 375-384.
30. Shen, L.; Kim, S.; Risacher, S. L.; Nho, K.; Swaminathan, S.; West, J. D.; et al. (2010). Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage, 53, 1051-1063.
31. Takei, N.; Miyashita, A.; Tsukie, T.; Arai, H.; Asada, T.; Imagawa, M.; et al. (2009). Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics, 93, 441-448.
32. Xiao, Z.; Xiao, J.; Jiang, Y.; Zhang, S.; Yu, M.; Zhao, J.; et al. (2006). A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatology Research, 34, 150-155.
33. Yu, J. T.; Mao, C. X.; Zhang, H. W.; Zhang, Q.; Wu, Z. C.; Yu, N. N.; et al. (2011). Genetic association of rs11610206 SNP on chromosome 12q13 with late-onset Alzheimer's disease in a Han Chinese population. Clinica Chimica Acta, 412, 148-151.
34. Yu, C. E.; Seltman, H.; Peskind, E. R.; Galloway, N.; Zhou, P. X.; Rosenthal, E.; et al. (2007). Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics, 89, 655-665.
35. Zhou, X.; Miao, H.; Rausch, W. D.; Long, M.; Luo, X.; Yu, H.; et al. (2012). Association between apolipoprotein E gene polymorphism and Alzheimer's disease in Uighur and Han populations. Psychogeriatrics, 12, 83-87.